KRYSTLE MARTINEZ: Open Payments
NPI 1275203838 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,884 in 140 payments from 26 companies in 2025. Trend: 2023 $1,682 · 2024 $1,255 · 2025 $2,884
Food & beverage: $2,884
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $530 |
| Lilly USA, LLC | 22 | $381 |
| ABBVIE INC. | 15 | $313 |
| Sumitomo Pharma America, Inc. | 14 | $289 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $160 |
| SHIELD THERAPEUTICS INC | 10 | $141 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| PFIZER INC. | 6 | $121 |
| SCPHARMACEUTICALS INC. | 5 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
Products named: GEMTESA, Wegovy, MOUNJARO, Ozempic, VRAYLAR, Kerendia, REXULTI, ACCRUFER.
Industry payments across TX — which companies pay providers there.
